Alpha-gal syndrome

Main Article Content

Francesca Nalin
Rocco Scarmozzino
Alessandra Arcolaci
Bianca Olivieri
Marina Tommasi
Patrizia Bonadonna
Giovanna Zanoni

Keywords

Abstract

N/A

Abstract 78 | PDF Downloads 207 HTML Downloads 0 XML Downloads 4

References

1 Nalin F, Scarmozzino R, Arcolaci A, Olivieri B, Tommasi M, Bonadonna P, Zanoni G. Alpha-gal syndrome: when treat-ment of hypovolemic shock can lead to anaphylaxis. Allergol Immunopathol (Madr). 2024;52(3):60–4. 10.15586/aei.v52i3.1082

2 Barbaud A, Garvey LH, Torres M, Laguna JJ, Arcolaci A, Bonadonna P, et al. EAACI/ENDA position paper on drug provocation testing. Allergy. 2024;79(3):565–79. 10.1111/all.15996

3 Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219–32. 10.1111/all.12260

4 Kiewiet MG, Apostolovic D, Starkhammar M, Grundström J, Hamsten C, van Hage M. Clinical and serological characterization of the α-gal syndrome—Importance of atopy for symptom severity in a European cohort. J Allergy Clin Immunol Pract. 2020;8(6):2027–34. 10.1016/j.jaip.2020.02.016